A comparative assessment of the cytotoxicity and nitric oxide reducing ability of resveratrol, pterostilbene and piceatannol in transformed and normal mouse macrophages

References

• Alosi J, McDonald D, Schneider J, et al. (2010). Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. J Surg Res 161:195–201.
   PubMed Web of Science ®Google Scholar
• Azmi AS, Bhat SH, Hadi SM. (2005). Resveratrol-Cu(II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties. FEBS Lett 579:3131–3135.
   PubMed Web of Science ®Google Scholar
• Azmi AS, Bhat SH, Hanif S, Hadi SM. (2006). Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. FEBS Lett 580:533–538.
   PubMed Web of Science ®Google Scholar
• Bi X, Yang J, Dog Y, et al. (2005). Resveratrol inhibits nitric oxide and TNF-a secretion by lipopolysaccharide-activated microglia. Int Immunopharmacol 5:185–193.
   PubMed Web of Science ®Google Scholar
• Billack B, Radkar V, Adiabouah C. (2008). In vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogs. Cell Mol Biol Lett 13:553–569.
   PubMed Web of Science ®Google Scholar
• Calabrese E. (2010a). Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exp Toxicol 29:249–261.
   PubMed Web of Science ®Google Scholar
• Calabrese E. (2010b). Resveratrol: an assessment of its dose response an introduction. Hum Exp Toxicol 29:977–979.
   PubMed Web of Science ®Google Scholar
• Castro R, Lamas J, Morias P, et al. (2008). Resveratrol modulates innate and inflammatory responses in fish leucocytes. Vet Immunol Immunopathol 126:9–19.
   PubMed Web of Science ®Google Scholar
• Chan M, Chen K. (2006). Growth inhibition and cell death induction by resveratrol in human lung adenocarcinoma cells. Tzu Chi Med J 18:345–353.
   Google Scholar
• Chen C, Jang J, Li M, Surh Y. (2005). Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 331:993–1000.
   PubMed Web of Science ®Google Scholar
• Chiou Y, Tsai M, Nagabhushanam K, et al. (2011). Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. J Agric Food Chem 59:2725–2733.
   PubMed Web of Science ®Google Scholar
• Cichocki M, Paluszczak J, Szaefer H, et al. (2008). Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFκB, AP-1, COX-2, and iNOS in mouse epidermis. Mol Nutr Food Res 2008:S62–S70.
   Google Scholar
• Csaki C, Keshishzadeh N, Fisher K, Shakibaei M. (2008). Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol 75:677–687.
   PubMed Web of Science ®Google Scholar
• Das S, Vasanthi HR, Das DK. (2009). Resveratrol: biochemistry and functions. In: Fraga CG, ed. Plant phenolics and human health: biochemistry, nutrition, and pharmacology. Hoboken (NJ): John Wiley & Sons, Inc., 299–330.
   Google Scholar
• Decker EA. (1997). Phenolics: prooxidants or antioxidants? Nutr Rev 55:396–398..
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova A, Massiah M, Bozak R, et al. (2001). Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 98:3404–3409.
   PubMed Web of Science ®Google Scholar
• Empl MT, Albers M, Wang S, Steinberg P. (2015). The resveratrol tetramer r-viniferin induces a cell cycle arrest followed by apoptosis in the prostate cancer cell line LNCaP. Phytother Res 29:1640–1645.
   PubMed Web of Science ®Google Scholar
• Filomeni G, Graziani I, Rotilio G, Ciriolo M. (2007). Trans-resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr 2:295–305.
   PubMed Web of Science ®Google Scholar
• Fukuhara K, Nagakawa M, Nakanishi I, et al. (2006). Structural basis for DNA-cleaving activity of resveratrol in the presence of cu(II). Bioorg Med Chem 14:1437–1443.
   PubMed Web of Science ®Google Scholar
• Galati G, O'Brien PJ. (2004). Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Rad Biol Med 37:287–303.
   PubMed Web of Science ®Google Scholar
• Ghazali A, Ki O, Hamid H, et al. (2012). Effects of pterostilbene on o-deethylation and glutathione conjugation of drug metabolizing enzyme activities. Pharmacologia 3:456–461.
   Google Scholar
• Howitz K, Bitterman K, Cohen H, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196.
   PubMed Web of Science ®Google Scholar
• Itoh K, Chiba T, Takahashi S, et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236:313–322.
   PubMed Web of Science ®Google Scholar
• Jaiswal M, LaRusso N, Gores G. (2001). Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 281:626–634.
   PubMed Web of Science ®Google Scholar
• Jakubowska J, Mikula-Pietrasik J, Ksiazek K, Krawczyk H. (2014). Cytotoxicity studies of novel combretastatin and pterostilbene derivatives. BioMed Res Int 2014:320895. doi: 10.1155/2014/320895.
   PubMed Web of Science ®Google Scholar
• Jin C, Moon D, Lee K, et al. (2006). Piceatannol attenuates lipopolysaccharide-induced NF-κB activation and NF-κB-related proinflammatory mediators in BV2 microglia. Pharmacol Res 54:461–467.
   PubMed Web of Science ®Google Scholar
• Khor T, Huang M, Prawan A, et al. (2008). Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev Res 1:187–191.
   PubMed Web of Science ®Google Scholar
• Kim J, Cha Y-N, Surh Y-J. (2010). A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 690:12–23.
   PubMed Web of Science ®Google Scholar
• Kundu J, Shin Y, Kim S, Surh Y. (2006). Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 27:1465–1474.
   PubMed Web of Science ®Google Scholar
• Kundu JK, Surh YJ. (2009). Resveratrol: the biochemistry behind its anticancer effects. In: Fraga CG, ed. Plant phenolics and human health: biochemistry, nutrition, and pharmacology. Hoboken (NJ): John Wiley & Sons, Inc., 331–359.
   Google Scholar
• Langcake P, Pryce R. (1977). The secretion of resveratrol and the viniferins by grapevines in response to ultraviolet irradiation. Phytochemistry 16:1193–1196.
   Web of Science ®Google Scholar
• Lee H, Pak S, Almazari I, et al. (2010). Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling. Biochem Biophys 501:142–150.
   Web of Science ®Google Scholar
• Li Y, Ou L, Zhou F, et al. (2015). Linalool inhibits LPS-induced inflammation in BV2 microglia cells by activating Nrf2. Neurochem Res 40:1520–1525.
   PubMed Web of Science ®Google Scholar
• Lin W, Wu R, Wu T, et al. (2008). Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol 76:967–973.
   PubMed Web of Science ®Google Scholar
• Lyu J, Kim K, Cho S, et al. (2012). Dangkwisoo-san, an herbal medicinal formula, ameliorates acute lung inflammation via activation of Nrf2 and suppression of NF-κB. J Ethnopharmacol 140:147–116.
   Web of Science ®Google Scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cyto-toxicity assays. J Immunol Methods 65:55–63.
   PubMed Web of Science ®Google Scholar
• Murias M, Jager W, Handler N, et al. (2005). Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship. Biochem Pharmacol 69:903–912.
   PubMed Web of Science ®Google Scholar
• Narisawa T, Takahashi M, Niwa M, et al. (1987). Involvement of prostaglandin E2 in bile acid-caused promotion of colon carcinogenesis and anti-promotion by the cyclooxygenase inhibitor indomethacin. J Cancer Res 78:791–798.
   Google Scholar
• Ozcan T, Akpinar-Bayizit A, Yilmaz-Ersan L, Delikanli B. (2014). Phenolics in human health. Int J Chem Eng Appl 5:393–396.
   Google Scholar
• Pan M, Chang Y, Tsai M, et al. (2008). Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. J Agric Food Chem 56:7502–7509.
   PubMed Web of Science ®Google Scholar
• Perecko T, Jancinova V, Drabikova K, et al. (2008). Structure–efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene. Neuroendocrinol Lett 29:802–805.
   PubMed Web of Science ®Google Scholar
• Pervaiz S. (2003). Resveratrol: from grapevines to mammalian biology. FASEB J 17:1975–1984.
   PubMed Web of Science ®Google Scholar
• Piotrowska H, Kucinska M, Murias M. (2012). Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat Res 750:60–82.
   PubMed Web of Science ®Google Scholar
• Radkar V, Hardej D, Lau-Cam C, Billack B. (2007). Evaluation of resveratrol and piceatannol cytotoxicity in macrophages, T cells and skin cells. Arch Ind Hyg Toxicol 58:293–304.
   Google Scholar
• Radkar V, Lau-Cam C, Hardej D, Billack B. (2008). The role of surface receptor stimulation on the cytotoxicity of resveratrol to macrophages. Food Chem Toxicol 46:3664–3670.
   PubMed Web of Science ®Google Scholar
• Ramos-Gomez M, Kwak M, Dolan P, et al. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 98:3410–3415.
   PubMed Web of Science ®Google Scholar
• Raschke W, Baird S, Ralph P, Nakoinz I. (1978). Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261–267.
   PubMed Web of Science ®Google Scholar
• Rimando A, Kalt W, Magee J, et al. (2004). Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 52:4713–4719.
   PubMed Web of Science ®Google Scholar
• Roupe K, Remsberg C, Yanez J, Davies N. (2006a). Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 1:81–101.
   PubMedGoogle Scholar
• Roupe K, Yáñez J, Teng X, Davies N. (2006b). Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. J Pharm Pharmacol 58:1443–1450.
   PubMed Web of Science ®Google Scholar
• Shin HS, Kang SI, Park DB, Kim SJ. (2016). Resveratrol suppresses inflammatory responses and improves glucose uptake in adipocytes interacted with macrophages. Genes Genom 38:137–143.
   Web of Science ®Google Scholar
• Signorelli P, Ghidoni R. (2005). Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16:449–466.
   PubMed Web of Science ®Google Scholar
• Spanier G, Xu H, Xia N, et al. (2009). Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 60:111–116.
   PubMed Web of Science ®Google Scholar
• Takaoka M. (1940). Of the phenolic substances of white hellebore. J Faculty Sci Hokkaido Univ 3:1–16.
   Google Scholar
• Thimmulappa R, Scollick C, Traore K, et al. (2006). Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-imidazolide. Biochem Biophys Res Commun 351:883–889.
   PubMed Web of Science ®Google Scholar
• Thomzik J, Stenzel K, Stöcker R, et al. (1997). Synthesis of a grapevine phytoalexin in transgenic tomatoes conditions resistance against Phytophthora infestans. Physiol Mol Plant Pathol 51:265–278.
   Web of Science ®Google Scholar
• Tolomeo M, Grimaudo S, Di Cristina A, et al. (2005). Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BRC-ABL-expressing leukemia cells. Int J Biochem Cell Biol 37:1709–1726.
   PubMed Web of Science ®Google Scholar
• Tsai S, Lin-Shiau S, Lin J. (1999). Suppression of nitric oxide synthase and the down-regulation of the activation of NFkB in macrophages by resveratrol. Br J Pharmacol 126:673–680.
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Bagi Z, Feher A, et al. (2010). Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol 299:18–24.
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, et al. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40.
   PubMed Web of Science ®Google Scholar
• Vane J, Mitchell J, Appleton I, et al. (1994). Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 91:2046–2050.
   PubMed Web of Science ®Google Scholar
• Vo T, Madlener S, Bago-Horvath Z, et al. (2010). Pro- and anti-carcinogenic mechanisms of piceatannol are activated dose-dependently in MCF-7 breast cancer cells. Carcinogenesis 31:2074–2081.
   PubMed Web of Science ®Google Scholar
• Wieder T, Prokop A, Bagci B, et al. (2001). Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia 11:1735–1742.
   Google Scholar
• Win W, Cao Z, Peng X, et al. (2002). Different effects of genistein and resveratrol on oxidative DNA damage in vitro. Mutat Res 513:113–120.
   PubMed Web of Science ®Google Scholar
• Zhu H, Jia Z, Zhang L, et al. (2008). Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress. Exp Biol Med 233:463–474.
   Web of Science ®Google Scholar